# Dermata Therapeutics (DRMA) — Earnings

DRMA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/drma/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$1.66 |
| EPS estimate | −$2.90 |
| EPS surprise | +42.76% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Aug 13, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1853816/000164117225023572/form10-q.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 13, 2025 | −$2.90 | −$1.66 | 42.76% | — | — |
| Q1 2025 | May 14, 2025 | −$4.50 | −$4.50 | 0.00% | — | — |
| Q4 2024 | Mar 17, 2025 | −$15.00 | −$13.40 | 10.67% | — | — |
| Q3 2024 | Nov 13, 2024 | −$26.40 | −$20.40 | 22.73% | — | — |
| Q2 2024 | Aug 7, 2024 | −$37.90 | −$41.80 | -10.29% | — | — |
| Q1 2024 | May 15, 2024 | −$54.00 | −$4.70 | 91.30% | — | — |
| Q4 2023 | Mar 21, 2024 | −$117.00 | −$67.50 | 42.31% | — | — |
| Q3 2023 | Nov 9, 2023 | −$94.50 | −$81.00 | 14.29% | — | — |
| Q2 2023 | Aug 10, 2023 | −$138.00 | −$94.50 | 31.52% | — | — |
| Q1 2023 | May 11, 2023 | −$397.50 | −$340.50 | 14.34% | — | — |
| Q4 2022 | Feb 21, 2023 | −$480.00 | −$336.00 | 30.00% | — | — |
| Q3 2022 | Nov 10, 2022 | −$528.00 | −$480.00 | 9.09% | — | — |
| Q2 2022 | Aug 15, 2022 | −$768.00 | −$576.00 | 25.00% | — | — |
| Q1 2022 | May 16, 2022 | −$960.00 | −$792.00 | 17.50% | — | — |
| Q4 2021 | Mar 28, 2022 | −$1,008.00 | −$744.00 | 26.19% | — | — |
| Q2 2021 | Sep 27, 2021 | −$1,680.00 | −$1,680.00 | 0.00% | — | — |

## Frequently Asked Questions

### When did Dermata Therapeutics (DRMA) last report earnings?

Dermata Therapeutics last reported on Aug 13, 2025, covering fiscal Q2 2025.

### Did DRMA beat earnings estimates?

Yes. Dermata Therapeutics reported EPS of −$1.66 for Q2 2025 against a −$2.90 estimate — a 42.76% beat.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).